Most people are unaware that Congenital Heart Defects (CHDs) are the most common birth defect in America. Approximately one in one hundred, or 40,000 newborns, are born with a CHD each year. CHDs are the most common cause of infant death related to birth defects. However, because of advancements made through research, death rates from CHDs in the U.S. have declined by 37.5%. It's our goal to see that number increase, and to continue to see babies born with CHDs survive to adulthood. All of which is only possible through research.

The Children's Heart Foundation (CHF)'s mission is to fund the most promising research to advance the diagnosis, treatment and prevention of congenital heart defects. Since 1996 CHF has independently funded 71 research projects with $9.1 million. In addition, CHF has co-funded 26 research projects with over $3.2 million with the American Heart Association through the CHD Research Awards. In total, CHF has funded 99 research projects with over $10.6 million.

To see the research CHF has funded, click here.


AHA/CHF CHD Research Awards

The Children’s Heart Foundation (CHF) partnered with the American Heart Association (AHA) to establish the AHA/CHF Congenital Heart Defect Research Awards. Through the AHA/CHF CHD Research Awards a total of $22.5 million will be awarded through 2021 to provide support for investigators who are actively conducting basic, clinical, population or translational research directly related to congenital heart defects (CHD).

For more information, including deadlines for the next round of funding, please visit:


Impact of CHD Research

Because of advancements made through research, more infants with CHD survive to adulthood. Meet Drew (below). The research study decribed in the image below has a special meaning
to Drew and his family, along with other families facing the challenges of HLHS.